While we are lowering our price target to $6, from $8, we view UIS shares attractively valued following the over 20% drop in the share price yesterday compared to the drop in the Russel 2000 Index of 1.86%
3Q:25 results were negative affected mainly driven by a large licensing renewal which was pushed into early 4Q:25. Management scaled back on its 2025 revenue guidance but maintained the non-GAAP operating margin guidance and free cash flow target of $110 million pre-pension funding.
While the company is experiencing headwinds in the revenue growth due to macro-economic uncertainties it is laser focused on expenses and cash flow and should be well positioned to expand profitability as they return to revenue growth.
07 Nov 2025
3Q:25 Results Reflect Timing; Lower 2026 Projections, On Macro Uncertainty; Execution Is Strong With Focus On Margins, Cash Flow; Lower Target To $6, From $8, Maintain High Risk Rating
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
3Q:25 Results Reflect Timing; Lower 2026 Projections, On Macro Uncertainty; Execution Is Strong With Focus On Margins, Cash Flow; Lower Target To $6, From $8, Maintain High Risk Rating
While we are lowering our price target to $6, from $8, we view UIS shares attractively valued following the over 20% drop in the share price yesterday compared to the drop in the Russel 2000 Index of 1.86%
3Q:25 results were negative affected mainly driven by a large licensing renewal which was pushed into early 4Q:25. Management scaled back on its 2025 revenue guidance but maintained the non-GAAP operating margin guidance and free cash flow target of $110 million pre-pension funding.
While the company is experiencing headwinds in the revenue growth due to macro-economic uncertainties it is laser focused on expenses and cash flow and should be well positioned to expand profitability as they return to revenue growth.